Please login to the form below

Not currently logged in
Email:
Password:

adverse event reporting

This page shows the latest adverse event reporting news and features for those working in and with pharma, biotech and healthcare.

Novo's semaglutide beats Lilly's Trulicity in diabetes contest

Novo's semaglutide beats Lilly's Trulicity in diabetes contest

The number of people reporting an adverse event of diabetic retinopathy was low and comparable in both the semaglutide and dulaglutide groups - at four and five events, respectively - according to Novo.

Latest news

  • Yolo Communications forms social media partnership Yolo Communications forms social media partnership

    Harta suggested that healthcare and pharma firms have shied away from using social data because of “ the (understandable) concern of negative implications and potential adverse event reporting”.

  • FDA warns of safety concern with SGLT2 inhibitors FDA warns of safety concern with SGLT2 inhibitors

    its Adverse Event Reporting System (AERS).

  • The behavioural science of adherence The behavioural science of adherence

    It's also essential to understand the legal and regulatory frameworks that govern the rules of adverse event reporting and data protection laws. ... Regional industry bodies all have strict guidelines for how adverse events should be reported, so a clear

  • EMA expands adverse event reporting website EMA expands adverse event reporting website

    EMA expands adverse event reporting website. Opens it up to all nationally-authorised medicines. ... The EMA has expanded the remit of its adverse event reporting website – allowing patients, the public and healthcare professionals to report suspected

  • Smartphone and social media adverse event project launched Smartphone and social media adverse event project launched

    Smartphone and social media adverse event project launched. The EU consortium's members will include UK regulator the MHRA. ... for reporting forms to be provided on these platforms to ensure regulators receive ADR reports that are easy to access and

More from news
Approximately 2 fully matching, plus 41 partially matching documents found.

Latest Intelligence

  • Up close and personal Up close and personal

    In spite of the lingering concerns and uncertainty around adverse event reporting, even for the more cautious companies, being left out may well present a bigger risk than treading the unfamiliar

  • Does safety sell medicines? Does safety sell medicines?

    in knots with strict rules regarding adverse event reporting. ... The adverse event information collected in the web portal is in turn sent to the company immediately.

  • A rough guide to... advisory boards A rough guide to... advisory boards

    Compliance Diligence with 'Fair market value', disclosure and adverse-event reporting builds trust.

  • Using social data to see patients more clearly Using social data to see patients more clearly

    A challenge presented by analysing social data for adverse drug events is establishing causality. ... Given that the FDA receives more than a million adverse event reports each year, the current reporting system will inevitably fail to capture all of the

  • The EMA's literature screening service and pharma The EMA's literature screening service and pharma

    Looking at this in more detail, if the market authorisation holder finds an article reporting that an adverse event is not serious and happens in an EEA country member, or if ... an adverse event is serious, then the market authorisation holder is

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics